redirecting...

Webcast
Allergan plc at the Barclays Global Healthcare Conference (Replay)
03/14/17 at 10:15 a.m. ET
Keyword Search
03.27.2017
Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline for the Treatment of Moderate to Severe Acne
03.22.2017
Allergan Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Ophthalmic Emulsion) 0.05% -- the First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle
03.20.2017
JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Facial Wrinkles and Folds in Adults over the Age of 21
03.14.2017
New Survey Reveals Impact Of Double Chin On Self-Perception And Behavior
03.14.2017
Award Winning Actor And Hip-Hop Artist Common Joins Allergan's See America(SM) Initiative To Further The Fight Against Preventable Blindness
<>